论文部分内容阅读
Objective The aim of this study was to study the effect of miR-375 on non-small cell lung carcinoma (NSCLC) invasion, migration, and proliferation through the CIP2A pathway.Methods We constructed a stable over-expressing cell line with lentivirus as the experimental group (Lv-miR-375) and transfected the empty vector as the negative control group (Lv-NC). The expression level of miR-375 was detected using real-time fluorescence quantitative PCR (qRT-PCR).West blots were used to detect the expression levels of cancerous inhibitor of PP2A (CIP2A), MYC, protein kinase B (AKT) and p-AKT in Lv-NC- and Lv-miR-375-transfected cells. Transwell assays were conducted to detect the cell invasion and metastasis ability, and the cell counting kit-8 (CCK8) was used to detect cell proliferation. Results qRT-PCR showed that miR-375 was overexpressed in NSCLC. Compared to the Lv-NC-transfected cells, the west blot results showed that CIP2A, MYC and p-AKT were highly expressed in Lv-miR-375-transfected cells. Transwell assays showed that the invasion and migration ability of Lv-miR-375-transfected A549 cells was significantly higher than that of Lv-NC-transfected cells. CCK8 experiments showed that compared to Lv-NC-transfected cells, the cell proliferation ability of the Lv-miR-375-transfected cells increased. Conclusion MiR-375 could promote the invasion, migration, and proliferation of NSCLC A549 cells via the CIP2A pathway. MiR-375 is expected to become a new target for the treatment of NSCLC, and may become an important biomarker for the diagnosis, prognosis, and treatment of the disease.